Madison, Virginia (PRWEB) April 10, 2014
Professor Fritz Buhler was recognized at the 17th International Conference on Pharmaceutical Medicine (ICPM) in Berlin last Friday, March 21, with a "Laudation" citation and speech by colleague Gerfried Nell, MD. The ICPM is organized every two to three years by IFAPP (International Federation of Associations of Pharmaceutical Physicians & Pharmaceutical Medicine) and a national member organization of Pharmaceutical Physicians (see http://www.icpm2014.com/). Heralded as “The Great Educator”, Professor Buhler was praised for his never ceasing efforts to establish better models of education in Pharmaceutical Medicine and Medicines Development.
Professor Buhler is a co-founder and Partner in NDA Partners LLC, a global strategy consulting firm specializing in medical product development. In the course of his formidable career, he was founder of the European Course in Pharmaceutical Medicine (ECPM), Managing Partner in Bear Stearns Health Innoventures in New York, co-founder and promoter of the tri-national BioValley at the Upper Rhine, co-founder of both the American and China Course on Drug Development and Regulatory Sciences, and Head of Global Clinical Research & Development at Hoffman-La Roche. He retains his position as Professor of Pharmaceutical Medicine and Pathophysiology as well as of Internal Medicine and Cardiology at the Faculty of Medicine, University of Basel, Switzerland.
“Professor Buhler has been a great source of inspiration to many who have interacted with him over the years”, stated Carl Peck, MD, Chairman of NDA Partners. “He is an energetic, creative, strong leader and global thinker, and we are honored to have him as a Partner in our firm.”
About NDA Partners
NDA Partners is a strategy consulting firm specializing in expert product development and regulatory advice to the medical products industry and associated service industries such as law firms, investment funds and government research agencies. The highly experienced Principals and Premier Experts of NDA Partners include two former FDA Center Directors, the former Chairman of the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK, an international team of approximately 30 former pharmaceutical industry and regulatory agency senior executives, and an extensive team of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, clinical development, regulatory submissions, and development program management. Services include expert consulting, product development planning, regulatory strategy, product assessments and due diligence, and associated support projects.